Former Turing Pharmaceuticals CEO Martin Shkreli testifies before the House Oversight Committee hearing on drug price hikes, … source
CNBC’s Meg Tirrell dissects the latest biotech news making headlines today, including raising the price for Daraprim from $13.50 … source
CNBC’s Meg Tirrell reports that the verdict in Martin Shkreli’s trial is in. The jury found Shkreli guilty of two counts of securities fraud and one...
Former Turing Pharmaceuticals CEO Martin Shkreli’s Attorney Benjamin Brafman speaks to the press after Shkreli was excused … source
On this website we use first or third-party tools that store small files (cookie) on your device. Cookies are normally used to allow the site to run properly (technical cookies), to generate navigation usage reports (statistics cookies) and to suitable advertise our services/products (profiling cookies). We can directly use technical cookies, but you have the right to choose whether or not to enable statistical and profiling cookies. Enabling these cookies, you help us to offer you a better experience.